Martin V. Mulroy

ABAXIS, Inc. engages in the development, manufacture, and marketing of portable blood analysis systems. It operates through the following segments: Medical Market, Veterinary Market, and Other. The Medical Market segment serves a customer group consisting of physicians’ office practices across multiple specialties, urgent care, outpatient and walk-in clinics, health screening operations, home care providers, nursing homes, ambulance companies, oncology treatment clinics, dialysis centers, pharmacies, hospital laboratories, military installations, pharmaceutical clinical trials, and cruise ship lines. The Veterinary Market segment focuses on animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies, and private research laboratories. The company was founded by Vladimir E. Ostoich in April 1989 and is headquartered in Union City, CA.

Beluga Composites Corp. develops and manufactures immunodiagnostic testing systems and related therapeutic drug monitoring systems. The firm's products include single water tanks, double water tanks, container series tanks, compartment tanks and accessories. The company is headquartered in Montreal, Canada.

Part of Resonac Holdings Corp., MAST Immunosystems, Inc. is a company that specializes in providing quality allergy care through their comprehensive panel test for environmental and food allergens called OPTIGEN® Allergen-Specific IgE Assay. The company is based in Mountain View, CA. The company also offers the OPTIGEN® Multiplex Allergen-Specific IgE Assay and the AP3600™ Fully-Automated System for OPTIGEN Allergy. MAST Immunosystems was acquired by Resonac Corp., part of Resonac Holdings Corp. from April 20, 2020 on November 04, 1996 for $40 million.